Form 8-K - Current report:
SEC Accession No. 0001104659-18-021260
Filing Date
2018-03-29
Accepted
2018-03-29 16:05:34
Documents
1
Period of Report
2018-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a18-9181_18k.htm 8-K 17910
  Complete submission text file 0001104659-18-021260.txt   19240
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 18722982
SIC: 2834 Pharmaceutical Preparations